Competition ABM/2022/4
On May 31, 2022, the Medical Research Agency (ABM) announced the Competition: “Competition for the elaboration and development of the innovative solutions in the field of new pharmaceutical forms of authorized medicinal products authorized, generic and biosimilar drugs and ABM/2022/4”.
The aim of the Competition is to provide financial support to the entrepreneurs for research and development of innovative solutions in the field of medicinal products, such as:
- generics;
- biosimilars;
- or new forms of already authorized drugs:
- new pharmaceutical forms;
- modified release products;
- combination medicinal products.
The implementation of the above is aimed at increasing Poland’s pharmaceutical safety, strengthening the health care system and facilitating patients’ access to cheaper therapies.
If you cooperate with entities from the private sector which conduct activities defined within the Competition frames, we encourage you to contact the Clinical Trials Support Center to discuss the possibility of participating in the project.
Extra points at proposal evaluation can be granted if the Project covers at least one of the below areas:
- cancer, diabetes, cardiovascular and respiratory diseases;
- rare diseases;
- childhood diseases;
- Infectious diseases.
More details are available here: LINK